A programmed cell death learning signature predicts immunotherapy response and identifies AP1S1 as a regulator of immune exclusion in breast cancer.
- DOI
- 10.21147/j.issn.1000-9604.2026.04.08
- Published
- 2026 Aug 30
- Container
- Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21147/j.issn.1000-9604.2026.04.08,
title = {A programmed cell death learning signature predicts immunotherapy response and identifies AP1S1 as a regulator of immune exclusion in breast cancer.},
author = {Wang G and Cao J and Kaysar P and Lu C and Chen Z and Chen Z and Zhang H and Yu Y and Xie Y and Cheng S and Zhang P and Wang X},
year = {2026},
journal = {Chinese journal of cancer research = Chung-kuo yen cheng yen chiu},
doi = {10.21147/j.issn.1000-9604.2026.04.08},
url = {https://doi.org/10.21147/j.issn.1000-9604.2026.04.08}
}RIS
TY - JOUR TI - A programmed cell death learning signature predicts immunotherapy response and identifies AP1S1 as a regulator of immune exclusion in breast cancer. AU - Wang G AU - Cao J AU - Kaysar P AU - Lu C AU - Chen Z AU - Chen Z AU - Zhang H AU - Yu Y AU - Xie Y AU - Cheng S AU - Zhang P AU - Wang X PY - 2026 JO - Chinese journal of cancer research = Chung-kuo yen cheng yen chiu DO - 10.21147/j.issn.1000-9604.2026.04.08 UR - https://doi.org/10.21147/j.issn.1000-9604.2026.04.08 ER -
APA
G, W., J, C., P, K., C, L., Z, C., Z, C., H, Z., Y, Y., Y, X., S, C., P, Z., & X, W. (2026). A programmed cell death learning signature predicts immunotherapy response and identifies AP1S1 as a regulator of immune exclusion in breast cancer.. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu. https://doi.org/10.21147/j.issn.1000-9604.2026.04.08
Source records
- pubmed · retrieved 2026-09-26T04:03:39.281Z
- europe-pmc · retrieved 2026-09-26T04:03:39.270Z